Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 17 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-6.46 Insider Own12.35% Shs Outstand2.86M Perf Week17.09%
Market Cap5.29M Forward P/E- EPS next Y-2.11 Insider Trans21.71% Shs Float2.51M Perf Month-7.50%
Income-9.83M PEG- EPS next Q-0.98 Inst Own3.72% Short Float0.90% Perf Quarter-19.21%
Sales0.00M P/S- EPS this Y54.01% Inst Trans4.99% Short Ratio0.02 Perf Half Y-85.90%
Book/sh3.11 P/B0.59 EPS next Y45.90% ROA-87.82% Short Interest0.02M Perf Year-84.58%
Cash/sh3.12 P/C0.59 EPS next 5Y15.00% ROE-103.29% 52W Range1.40 - 18.00 Perf YTD-72.36%
Dividend Est.- P/FCF- EPS past 5Y9.70% ROI-109.98% 52W High-89.72% Beta0.54
Dividend TTM- Quick Ratio9.70 Sales past 5Y0.00% Gross Margin- 52W Low32.14% ATR (14)0.20
Dividend Ex-Date- Current Ratio9.70 EPS Y/Y TTM80.82% Oper. Margin0.00% RSI (14)51.60 Volatility15.51% 9.94%
Employees13 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q68.71% Payout- Rel Volume0.11 Prev Close1.75
Sales Surprise- EPS Surprise5.93% Sales Q/Q- EarningsMay 10 Avg Volume1.46M Price1.85
SMA207.00% SMA50-4.24% SMA200-62.82% Trades Volume157,826 Change5.71%
Date Action Analyst Rating Change Price Target Change
Apr-25-24Initiated H.C. Wainwright Buy $8
Jun-11-24 08:20AM
May-13-24 10:53AM
May-06-24 08:00AM
Apr-30-24 08:00AM
Apr-11-24 08:00AM
08:15AM Loading…
Mar-28-24 08:15AM
Mar-25-24 08:15AM
Feb-21-24 08:15AM
Feb-14-24 01:00PM
Feb-06-24 08:30AM
Feb-01-24 04:22PM
Jan-26-24 09:04AM
Jan-25-24 02:40PM
Jan-19-24 07:45AM
07:45AM Loading…
Jan-18-24 07:45AM
Jan-02-24 05:06PM
Dec-19-23 09:00AM
Dec-13-23 09:00AM
Nov-30-23 08:15AM
Nov-29-23 08:15AM
Nov-13-23 01:40PM
Nov-09-23 08:15AM
Nov-01-23 08:15AM
Oct-13-23 01:08PM
Sep-06-23 08:15AM
Aug-17-23 08:05AM
Aug-15-23 10:20AM
Aug-10-23 04:15PM
Aug-08-23 08:15AM
04:15PM Loading…
Jun-14-23 04:15PM
Jun-13-23 08:30AM
May-22-23 08:05AM
May-18-23 08:00AM
Apr-28-23 08:15AM
Mar-30-23 04:01PM
Mar-23-23 08:30AM
Mar-17-23 08:30AM
Mar-07-23 08:30AM
Feb-21-23 08:30AM
Feb-15-23 08:30AM
Feb-10-23 08:00AM
Jan-04-23 08:30AM
Dec-14-22 08:30AM
Nov-08-22 04:00PM
Nov-02-22 08:30AM
Nov-01-22 08:30AM
Sep-15-22 08:30AM
Sep-07-22 08:30AM
Aug-16-22 08:30AM
Aug-12-22 09:30AM
Aug-05-22 03:00PM
Aug-04-22 09:30AM
Aug-03-22 04:00PM
Jul-12-22 08:30AM
Jun-24-22 09:06AM
May-12-22 04:20PM
May-05-22 08:30AM
Apr-20-22 08:30AM
Apr-05-22 08:30AM
Mar-30-22 04:00PM
Mar-23-22 08:30AM
Mar-10-22 08:30AM
Jan-26-22 08:15AM
Jan-17-22 08:42AM
Nov-11-21 04:05PM
Nov-04-21 08:15AM
Oct-26-21 08:30AM
Oct-19-21 10:22AM
Oct-12-21 08:30AM
Sep-16-21 11:05AM
Aug-23-21 04:00PM
Aug-20-21 10:54AM
Aug-12-21 05:15PM
Aug-06-21 08:30AM
Aug-05-21 09:51AM
Aug-04-21 08:30AM
Jul-27-21 08:30AM
Jul-08-21 11:20AM
Jul-06-21 08:15AM
Jun-23-21 09:35AM
Jun-17-21 09:15AM
Jun-08-21 09:15AM
Jun-07-21 04:05PM
May-26-21 09:15AM
May-20-21 04:05PM
May-18-21 04:05PM
May-13-21 04:55PM
May-07-21 08:30AM
Mar-25-21 04:06PM
Mar-22-21 09:15AM
Mar-17-21 09:15AM
Mar-02-21 09:15AM
Feb-22-21 08:30AM
Feb-19-21 05:16AM
Feb-17-21 08:00AM
Jan-11-21 10:50AM
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young DavidPres. Research & DevelopmentFeb 07 '24Buy2.4521,00051,52679,387Feb 08 04:30 PM
Young DavidPres. Research & DevelopmentFeb 06 '24Buy2.5320,00050,50458,387Feb 07 04:22 PM
Lin PatrickChief Business - Strategy OffFeb 01 '24Buy2.401,5003,60027,478Feb 01 06:32 PM
Lin PatrickChief Business - Strategy OffJan 31 '24Buy2.372,5005,92525,978Feb 01 06:32 PM
Ng George KChief Executive OfficerJan 30 '24Buy2.7010,00027,00020,000Jan 31 04:37 PM
Yorke Justin WDirectorJan 30 '24Buy2.698,00021,54431,232Jan 31 04:34 PM